Bioartificial organ manufacturing plays a vital role in developing artificial vital organs. Based on the materials used, artificial organs can be divided into three main classes: mechanical, biomechanical and biological.
The global artificial vital organs and medical bionics market is estimated to account for US$ 38,658.6 Mn in terms of value and is expected to reach US$ 73,316.9 Mn by the end of 2027.
Global Artificial Vital Organs and Medical Bionics Market: Drivers
Increasing approval and launch of artificial organs is expected to propel growth of the global artificial vital organs and medical bionics market. For instance, in March 2020, SynCardia Systems, LLC received the U.S. Food and Drug Administration (FDA) approval for its 50cc temporary Total Artificial Heart (TAH) System as a bridge to heart transplant.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3896
Global Artificial Vital Organs and Medical Bionics Market: Opportunities
R&D in artificial vital organs is expected to offer lucrative growth opportunities for players in the global artificial vital organs and medical bionics market. For instance, in June 2018, researchers from Lodz University of Technology, Poland, reported development of artificial circulatory system that simulated various ejection pressures, ejection volumes, and frequencies of pulsation.
Global Artificial Vital Organs and Medical Bionics Market: Restraints
High cost involved in development of artificial organs and medical bionics is expected to limit growth of the market.
Key Takeaways:
The global artificial vital organs and medical bionics market was valued at US$ 35,340.4 Mn in 2019 and is forecast to reach a value of US$ 73,316.9 Mn by 2027 at a CAGR of 9.6% between 2020 and 2027. Major factor driving the growth of global artificial vital organs and medical bionics market during the forecast period include increasing waiting list for organ transplant, and increasing prevalence of chronic disorders.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3896
Artificial Vital Organs held dominant position in the global artificial vital organs and medical bionics market in 2019, accounting for 59.3% share in terms of value, followed by Medical Bionics. Increasing waiting list for organ transplant is expected to propel growth of the segment over the forecast period.
Market Trends
The market is witnessing increasing adoption of total artificial heart (TAH). For instance, May 2018, SynCardia Systems, LLC announced that Saint Thomas Health become the first health system in Tennessee (U.S.) to offer the SynCardia temporary TAH as part of its cardiac treatment services.
Organizations are focused on R&D on the role of extracorporeal membrane oxygenation in the management of severely ill patients with COVID-19. For instance, in April 2020, SpecialtyCare, a provider of perfusion, ECMO, intraoperative neuromonitoring, and surgical services, collaborated with the American Society for Artificial Organs to publish research on the role of extracorporeal membrane oxygenation in the management of severely ill patients with COVID-19.
Global Artificial Vital Organs and Medical Bionics Market: Competitive Landscape
Major players operating in the global artificial vital organs and medical bionics market include, SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
Browse Press Release: https://www.coherentmarketinsights.com/press-release/artificial-vital-organs-and-medical-bionics-market-3166
Global Artificial Vital Organs and Medical Bionics Market: Key Developments
February 2020: Ekso Bionics Holdings, Inc.announced that Post Acute Medical, LLC, a system of inpatient rehabilitation hospitals, has acquired three additional EksoNR devices from the company to expand the availability of exoskeleton-assisted rehabilitation to seven of its facilities.
October 2019: BiVACOR, Inc. collaborated with NASA’s Johnson Space Center to improve the robustness and reliability of the company’s TAH system.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3896
Segmentation
- By Type
- Artificial Vital Organs
- Artificial Heart
- Artificial Kidney
- Artificial Liver
- Artificial Pancreas
- Artificial Lungs
- Medical Bionics
- Cochlear Implants
- Vision Bionics
- Exoskeletons
- Bionic Limbs
- Brain Bionics
- Cardiac Bionics
- Artificial Vital Organs
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
